MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 70 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $133,000 | -30.0% | 42,306 | 0.0% | 0.00% | -50.0% |
| Q3 2019 | $190,000 | -8.7% | 42,306 | +22.8% | 0.00% | -33.3% |
| Q2 2019 | $208,000 | +23.1% | 34,439 | +41.7% | 0.00% | +50.0% |
| Q1 2019 | $169,000 | +3.7% | 24,300 | -42.4% | 0.00% | -33.3% |
| Q4 2018 | $163,000 | -27.6% | 42,205 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $225,000 | +21.0% | 42,205 | +11.6% | 0.00% | 0.0% |
| Q2 2018 | $186,000 | -50.0% | 37,805 | -18.2% | 0.00% | -50.0% |
| Q1 2018 | $372,000 | +78.0% | 46,205 | +126.5% | 0.01% | +50.0% |
| Q4 2017 | $209,000 | +5.6% | 20,400 | +50.0% | 0.00% | 0.0% |
| Q3 2017 | $198,000 | – | 13,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Standard LLC | 1,894,013 | $23,353,180 | 21.09% |
| Newtyn Management, LLC | 1,873,694 | $23,102,647 | 5.70% |
| Sio Capital Management, LLC | 288,466 | $3,556,786 | 1.10% |
| Madison Avenue Partners, LP | 553,085 | $6,819,538 | 0.97% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 209,739 | $2,586 | 0.95% |
| Indaba Capital Management, L.P. | 136,802 | $1,686,769 | 0.50% |
| Sepio Capital, LP | 306,680 | $3,781,364 | 0.33% |
| Yakira Capital Management, Inc. | 54,118 | $667,275 | 0.18% |
| Centiva Capital, LP | 187,803 | $2,315,611 | 0.05% |
| FIFTH LANE CAPITAL, LP | 10,929 | $134,427 | 0.05% |